Patent Assignment
Reel/Frame 051445/0936
Assignment of Assignor's Interest
Recorded: 2020-01-08
Pages: 4
Assignor
UCB BIOPHARMA SPRL
Executed: 2019-11-08
Assignees
SANOFI
54 RUE LA BOETIE, PARIS, F-75008, FRANCE
UCB BIOPHARMA SPRL
ALLEE DE LA RECHERCHE, 60, BRUSSELS, B-1070, BELGIUM
Covered Property
(1)
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 7, 2020
From: BROOKINGS, DANIEL CHRISTOPHER; BROWN, JULIAN ALISTAIR; HEER, JAG PAUL; JOHNSON, JAMES ANDREW
To: CELLTECH R&D LIMITED
Reel/Frame 051441/0281 →
Assignment of Assignor's Interest
Jan 7, 2020
From: CELLTECH R&D LIMITED
To: UCB S.A.
Reel/Frame 051441/0376 →
Assignment of Assignor's Interest
Jan 7, 2020
From: UCB S.A.
To: UCB PHARMA S.A.
Reel/Frame 051441/0397 →
Assignment of Assignor's Interest
Jan 7, 2020
From: UCB PHARMA S.A.
To: UCB BIOPHARMA SPRL
Reel/Frame 051441/0409 →
Change of Name
Jan 12, 2021
From: UCB BIOPHARMA SPRL (SOCIETE PRIVEE A RESPONSABILITE LIMITEE)
To: UCB BIOPHARMA SRL (SOCIETE A RESPONSABILITE LIMITEE)
Reel/Frame 054971/0876 →